Concepedia
Statistics
Publications
13
Citations
1.9K
H-Index
11
Active since
1991
Affiliations
Adaptimmune (United Kingdom)(Current)
Washington University in St. Louis
The University of Texas MD Anderson Cancer Center
Stanford University
Fox Chase Cancer Center
Tom Holdich is an author at Adaptimmune (United Kingdom) specializing in life sciences, immunology, and immunotherapy.
Publications per year
1991–2022
NY-ESO-1–specific TCR–engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport, Edward A. Stadtmauer, Gwendolyn Binder-Scholl et al. · Nature Medicine · 2015 · 848 citations · Full text
Life Sciences, Immunology, Oncology +16
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1 c259T Cells in Synovial Sarcoma
Sandra P. D’Angelo, Luca Melchiori, Melinda S. Merchant et al. · Cancer Discovery · 2018 · 435 citations · Full text
Life Sciences, Immunology, Oncology +17
Examination of some factors responsible for a food‐induced increase in absorption of atovaquone.
PE Rolan, AJ Mercer, BC Weatherley et al. · British Journal of Clinical Pharmacology · 1994 · 123 citations · Full text
Pharmacy, Nutritional Sciences, Pharmacology +17
566C80: a potent broad spectrum anti-infective agent with activity against malaria and opportunistic infections in AIDS patients.
Alan T. Hudson, Maurice Dickins, Colin D. Ginger et al. · PubMed · 1991 · 123 citations
Medicine, Medicinal Chemistry, Pharmacology +11
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen
L. DuBuske, Anthony J. Frew, Friedrich Horak et al. · Allergy and Asthma Proceedings · 2011 · 118 citations · Full text
Life Sciences, Immunology, Otolaryngology +14
1–5 of 13